Home › Funds › GSK plc › FULC

GSK plc position in FULC

FULCRUM THERAPEUTICS INC · Health Care

GSK plc reported holding 1,785,714 shares of FULC (FULCRUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.6M, representing 1.33% of its reported portfolio and ranking #10 among its reported holdings. GSK plc has disclosed FULC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.79M sh
Reported value held$6.61M
Portfolio Weight1.33%
First reportedQ4 2025
Last changeHold
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How GSK plc's FULC position evolved

GSK plc first disclosed a stake in FULC in Q4 2025 at 1,785,714 shares (US$20.2M). Across 4 filings, GSK plc held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,785,714 shares valued at US$6.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.79M $20.20M New
Q1 2026 1.79M $13.70M Hold
Q2 2026 1.79M $6.54M Hold
Q3 2026 1.79M $6.61M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FULC and 13F data

FULC (FULCRUM THERAPEUTICS INC) is a Health Care company. 30 other funds we track also report a position in FULC — the largest reported positions include EcoR1 Capital, LLC (US$24.0M), TANG CAPITAL MANAGEMENT LLC (US$23.9M), Nantahala Capital Management, LLC (US$20.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FULC

All FULC fund holders →

FAQ

How long has GSK plc held FULC?

GSK plc has disclosed FULC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is GSK plc's current position in FULC?

As of Q3 2026, GSK plc holds 1.79M shares of FULC (FULCRUM THERAPEUTICS INC), valued at $6.61M, representing 1.33% of its reported portfolio and ranking #10.

Has GSK plc been buying or selling FULC?

In the latest 13F filing (Q3 2026), GSK plc held unchanged its position in FULC.

Which other funds hold FULC?

Other major institutional holders of FULC include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Nantahala Capital Management, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.